NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT05291091,Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON),https://clinicaltrials.gov/study/NCT05291091,,ACTIVE_NOT_RECRUITING,"A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to include an additional 120 adult participants in a cohort called GRAND CANYON, that is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of sevasemten in adults with Becker.

CANYON is fully enrolled; GRAND CANYON is currently enrolling.",NO,Becker Muscular Dystrophy,DRUG: Sevasemten 10 mg|DRUG: Sevasemten 5 mg|DRUG: Sevasemten 12.5 mg|DRUG: Placebo,"Number of adverse events in those treated with sevasemten or placebo, All participants, 12 months (CANYON Cohorts 1, 2, 4, 5), 18 months (GRAND CANYON Cohort 6)|Severity of adverse events in those treated with sevasemten or placebo, All participants, 12 months (CANYON Cohorts 1, 2, 4, 5), 18 months (GRAND CANYON Cohort 6)|Change from Baseline in serum Creatine Kinase, Adult participants, 12 Months (CANYON Cohorts 1, 2)|Change from Baseline in the North Star Ambulatory Assessment scale, Adult participants, 18 months (GRAND CANYON Cohort 6)","Change from Baseline in the protein fast skeletal muscle Troponin I, Adult participants, 12 months (CANYON Cohorts 1, 2), 18 months (GRAND CANYON Cohort 6)|Change from Baseline in the North Star Ambulatory Assessment scale, Adult participants, 12 Months (CANYON Cohorts 1, 2)|Change from Baseline in the North Star Assessment for Limb-Girdle Type Muscular Dystrophies scale, Adult participants, 12 Months (CANYON Cohorts 1, 2), 18 Months (GRAND CANYON Cohort 6)|Change from Baseline in the 10-meter walk/run test, Adult participants, 12 Months (CANYON Cohorts 1, 2), 18 Months (GRAND CANYON Cohort 6)|Change from Baseline in 100-meter timed test, Adult participants, 12 Months (CANYON Cohorts 1, 2), 18 Months (GRAND CANYON Cohort 6)|Change from Baseline in stride velocity (95th percentile), Adult participants, 18 Months (GRAND CANYON Cohort 6)|Pharmacokinetics as measured by steady state plasma concentration, All participants, 12 Months (CANYON Cohorts 1, 2, 4, 5), 18 months (GRAND CANYON Cohort 6)|Change from Baseline in growth as assessed by height centile on World Health Organization growth charts, Adolescent participants, 12 months (CANYON Cohorts 4, 5)|Month 18 change from Baseline in fat fraction of upper leg muscles as assessed by Magnetic Resonance Imaging, Adult participants, 18 months (GRAND CANYON Cohort 6)",,"Edgewise Therapeutics, Inc.","Medpace, Inc.|ImagingNMD|SYSNAV",MALE,"CHILD, ADULT",PHASE2,175,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",EDG-5506-201,2022-07-06,2026-08,2026-08,2022-03-22,,2025-03-04,"Arkansas Children's Hospital, Little Rock, Arkansas, 72202, United States|UC San Diego, La Jolla, California, 92037, United States|UCLA Medical Center, Los Angeles, California, 90095, United States|UC Irvine Medical Center, Orange, California, 92868, United States|Stanford Neuroscience Health Center, Palo Alto, California, 94304, United States|UC Davis Medical Center, Sacramento, California, 95817, United States|UC Denver, Aurora, Colorado, 80045, United States|University of Florida, Gainesville, Florida, 32611, United States|Rare Disease Research, Atlanta, Georgia, 30329, United States|Northwestern University, Chicago, Illinois, 60611, United States|Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States|University of Iowa, Iowa City, Iowa, 52242, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Kennedy Krieger Institute, Baltimore, Maryland, 21205, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, 01605, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Rare Disease Research, LLC NC, Hillsborough, North Carolina, 27278, United States|University of Cincinnati Gardner Neuroscience Institute, Cincinnati, Ohio, 45219, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|National Neuromuscular Research Institute, Austin, Texas, 78759, United States|Neurology Rare Disease Center, Denton, Texas, 76208, United States|Virginia Commonwealth University Health, Richmond, Virginia, 23298, United States|St Vincent's Hospital Melbourne, Fitzroy, VIC, 3065, Australia|University Hospital Gent, Gent, 9000, Belgium|Universitaire Ziekenhuizen Leuven, Leuven, Belgium|Centre Hospitalier Régional de la Citadelle, Liège, 4000, Belgium|Rigshospitalet, Copenhagen, Denmark|Centre de Reference des Maladies Neuromusculaires et de la SLA - AP-HM Hopital de La Timone, Marseille, 13005, France|CHU de Nantes, Nantes Cedex, 44093, France|CHU de Nice - Hopital Pasteur 2 - Centre de reference des Maladies Neuromusculaires, Nice Cedex 1, 06001, France|AP-HP Hopital Pitie-Salpetriere, Paris, 75013, France|Klinikum der Ludwig-Maximilians-Universitaet Muenchen, Munich, 80336, Germany|Hadassah University Hospital, Jerusalem, 91240, Israel|Schneider Children's Hospital of Israel, Petah Tiqwa, 49202, Israel|Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico di Milano, Milan, 20122, Italy|Azienda Ospedale - Università Padova, Padova, 35128, Italy|Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome, 00168, Italy|Leids Universitair Medisch Centrum, Leiden, 2333 ZA, Netherlands|Optimal Clinical Trials, Auckland, 1010, New Zealand|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitari de Bellvitge, Barcelona, 08907, Spain|Hospital Universitario Donostia, San Sebastian, 20014, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|University College London Hospital, London, NW1 2PG, United Kingdom|St. George's University Hospitals NHS Foundation Trust, London, SW17 0QT, United Kingdom|Newcastle Freeman Hospital, Newcastle, NE7 7DN, United Kingdom|Salford Royal Hospital, Salford, M68HD, United Kingdom",
